Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Toshiyuki Kudo
Observed names:
Kudo, Toshiyuki,
T. Kudo,
Toshiyuki KUDO,
工藤, 季之
Institution:
Musashino University
Observed institutions:
Musashino University,
Hoshi University,
University of Tokyo Hospital,
RIKEN,
Tanabe Pharma Corporation (Japan),
The University of Tokyo,
Musashi University
show all 7
ORCID:
0000-0001-6010-7617
Observed ORCID:
0000-0001-6010-7617
OpenAlex ID:
A5026680599
Effects of Magnesium Sulphate Administration on Aquaporin 3 in Rat Gastrointestinal Tract
2011
·
Nobutomo Ikarashi
, Takashi Ushiki
, et al.
·
Biological and Pharmaceutical Bulletin
·
60
PDF
Ciprofloxacin Suppresses Cyp3a in Mouse Liver by Reducing Lithocholic Acid-producing Intestinal Flora
2009
·
Takahiro Toda
, Kanna Ohi
, et al.
·
Drug Metabolism and Pharmacokinetics
·
58
Preventive Effects of Bofutsushosan on Obesity and Various Metabolic Disorders
2008
·
Tsutomu Shimada
, Toshiyuki Kudo
, et al.
·
Biological and Pharmaceutical Bulletin
·
54
PDF
Estimation of changes in serum creatinine and creatinine clearance caused by renal transporter inhibition in healthy subjects
2019
·
Tomohisa Nakada
, Toshiyuki Kudo
, et al.
·
Drug Metabolism and Pharmacokinetics
·
49
Analysis of the Repaglinide Concentration Increase Produced by Gemfibrozil and Itraconazole Based on the Inhibition of the Hepatic Uptake Transporter and Metabolic Enzymes
2012
·
Toshiyuki Kudo
, Akihiro Hisaka
, et al.
·
Drug Metabolism and Disposition
·
39
Altered expression of CYP in TSOD mice: a model of type 2 diabetes and obesity
2009
·
T. Kudo
, T. Shimada
, et al.
·
Xenobiotica
·
34
Quantitative analysis of elevation of serum creatinine via renal transporter inhibition by trimethoprim in healthy subjects using physiologically-based pharmacokinetic model
2017
·
Tomohisa Nakada
, Toshiyuki Kudo
, et al.
·
Drug Metabolism and Pharmacokinetics
·
31
Bridging from Preclinical to Clinical Studies for Tyrosine Kinase Inhibitors Based on Pharmacokinetics/Pharmacodynamics and Toxicokinetics/Toxicodynamics
2011
·
Azusa Hoshino-Yoshino
, Motohiro Kato
, et al.
·
Drug Metabolism and Pharmacokinetics
·
26
Quantitative Consideration of Clinical Increases in Serum Creatinine Caused by Renal Transporter Inhibition
2023
·
Tomohisa Nakada
, Toshiyuki Kudo
, et al.
·
Drug Metabolism and Disposition
·
25
PDF
Evaluation of the appropriate time range for estimating the apparent permeability coefficient (Papp) in a transcellular transport study
2015
·
Kazuhisa Ozeki
, Motohiro Kato
, et al.
·
International Journal of Pharmaceutics
·
22
Differences in the pharmacokinetics of Cyp3a substrates in TSOD and streptozotocin-induced diabetic mice
2010
·
T. Kudo
, T. Toda
, et al.
·
Xenobiotica
·
21
Effects of proton pump inhibitors, esomeprazole and vonoprazan, on the disposition of proguanil, a CYP2C19 substrate, in healthy volunteers
2019
·
Ryohkan Funakoshi
, Yukana Tomoda
, et al.
·
British Journal of Clinical Pharmacology
·
17
Effect of buffer conditions on CYP2C8-mediated paclitaxel 6α-hydroxylation and CYP3A4-mediated triazolamα- and 4-hydroxylation by human liver microsomes
2015
·
Toshiyuki Kudo
, Yuya Ozaki
, et al.
·
Xenobiotica
·
17
Metronidazole reduces the expression of cytochrome P450 enzymes in HepaRG cells and cryopreserved human hepatocytes
2014
·
Toshiyuki Kudo
, Yumiko Endo
, et al.
·
Xenobiotica
·
17
Antibiotics Suppress Cyp3a in the Mouse Liver by Reducing Lithocholic Acid-producing Intestinal Flora
2009
·
Takahiro TODA
, Kanna OHI
, et al.
·
YAKUGAKU ZASSHI
·
17
PDF
Estimation of the Contribution of CYP2C8 and CYP3A4 in Repaglinide Metabolism by Human Liver Microsomes Under Various Buffer Conditions
2017
·
Toshiyuki Kudo
, Hitomi Goda
, et al.
·
Journal of Pharmaceutical Sciences
·
10
Pharmacokinetics of CuGTSM, a Novel Drug Candidate, in a Mouse Model of Menkes Disease
2021
·
Yoshiaki Yamagishi
, Toshiyuki Kudo
, et al.
·
Pharmaceutical Research
·
7
Chorea-like symptoms and high blood concentration of ceftriaxone in a patient undergoing hemodialysis: A case report
2019
·
Yoshiaki Yokoyama
, Naoto Hosokawa
, et al.
·
Journal of Infection and Chemotherapy
·
7
In vitro–in vivo extrapolation of metabolic clearance using human liver microsomes: factors showing variability and their normalization
2020
·
Keiichi Morita
, Motohiro Kato
, et al.
·
Xenobiotica
·
6
Investigation of the Safety of Topical Metronidazole from a Pharmacokinetic Perspective
2013
·
Junichi Iida
, Toshiyuki Kudo
, et al.
·
Biological and Pharmaceutical Bulletin
·
6
PDF
Caffeine consumption as a risk factor for childhood and adolescence migraine
2022
·
Toshiyuki Hikita
, Hitomi Goda
, et al.
·
Pediatrics International
·
4
Study of the Inhibitory Effects of Enteral Nutrition Formula on Indomethacin-Induced Gastric Lesions in Mice
2019
·
Takeshi Yoshimi
, Yoshiaki Yamagishi
, et al.
·
Nutrients
·
3
PDF
Physiologically based pharmacokinetic model analysis of the inhibitory effect of vonoprazan on the metabolic activation of proguanil
2023
·
Kenjiro Okubo
, Toshiyuki Kudo
, et al.
·
Drug Metabolism and Pharmacokinetics
·
1
Pharmacokinetics and safety of rilpivirine in healthy Japanese subjects and exploration of ethnic sensitivity of rilpivirine pharmacokinetics with physiologically based pharmacokinetic model approach
2021
·
Kentaro Ohta
, Nobuko Matsushima
, et al.
·
Drug Metabolism and Pharmacokinetics
·
1
Gastroprotective Effect of Enteral Nutrition Formula in Mice Injected Subcutaneously with Indomethacin
2021
·
Yoshiaki Yamagishi
, Rei Saiki
, et al.
·
Nutrients
·
1
PDF
Show more works
View as search
Works count:
35
Citation count:
533
H-index:
15
I10-index:
16
Year
Topic
Type
